Showing results (941-950 of 956) with videos related to
Sort By:
Pageof 96
Cancer Chemotherapy and Pharmacology|August 19, 2000
Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cellsK Tani, Y Nakazaki, H Hase, et al.Cancer Medicine|April 18, 2025
Regional Differences in the Frequency of BRCA1 and BRCA2 Variants in Northeastern Japan: A Cohort StudyHidekazu Shirota, Akimitsu Miyake, Maako Kawamura, et al.Cell|March 7, 2020
Ubiquitination of DNA Damage-Stalled RNAPII Promotes Transcription-Coupled RepairYuka Nakazawa, Yuichiro Hara, Yasuyoshi Oka, et al.Journal of Gastrointestinal Oncology|May 18, 2023
Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methylation status and the efficacy of the anti-EGFR antibody: T-CORE1201Shin Takahashi, Kota Ouchi, Yasuhiro Sakamoto, et al.The Journal of Experimental Medicine|July 18, 2023
TLR7/8 stress response drives histiocytosis in SLC29A3 disordersTakuma Shibata, Ryota Sato, Masato Taoka, et al.International Journal of Clinical Oncology|November 29, 2020
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)Yoichi Naito, Hiroyuki Aburatani, Toraji Amano, et al.International Journal of Clinical Oncology|May 22, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumorsYoichi Naito, Saori Mishima, Kiwamu Akagi, et al.International Journal of Clinical Oncology|August 20, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third editionSaori Mishima, Yoichi Naito, Kiwamu Akagi, et al.International Journal of Clinical Oncology|June 10, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumorsSaori Mishima, Yoichi Naito, Kiwamu Akagi, et al.Cancer Medicine|May 19, 2021
Recognition and pathological features of periampullary region adenocarcinoma with an indeterminable originRyuji Komine, Motohiro Kojima, Genichiro Ishi, et al.Pageof 96